Researchers say the number of circulating tumor cells in the blood is a “powerful predictor” to help physicians more reliably assess treatment benefit for patients with metastatic breast cancer.
Researchers say the number of circulating tumor cells in the blood is a “powerful predictor” to help physicians more reliably assess treatment benefit for patients with metastatic breast cancer.